Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The old and new screenshots show the same Record History content with only minor visual/layout adjustments; no data, version entries, or study details appear to have changed.
    Difference
    0.1%
    Check dated 2025-11-03T13:11:51.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.
    Difference
    9%
    Check dated 2025-10-05T17:41:29.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T11:18:52.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed.
    Difference
    0.5%
    Check dated 2025-09-14T00:47:30.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.5%
    Check dated 2025-09-06T21:27:44.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    54%
    Check dated 2025-08-30T15:59:13.000Z thumbnail image

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.